Forge Biologics

Forge Biologics is a distinguished Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) specialising in cell and gene therapy. The company operates as a gene therapy development engine, focusing on facilitating access to transformative gene therapies and assisting in their transition from concept to reality. Forge collaborates closely with key stakeholders in the gene therapy arena, including scientists, physicians, biotech and pharmaceutical companies, as well as patient advocacy groups, to deliver comprehensive manufacturing services. This enables the acceleration of gene therapy programmes from the preclinical phase through clinical trials to commercial manufacturing.

Services include:
- Contract Manufacturing (CMO)
- Contract Development and Manufacturing (CDMO)
- Gene Therapy Development
- Finished Dosage Formulation
- Plasmid Supply
- Viral Vector Supply

Forge Biologics is committed to driving innovation and accessibility in gene therapies, making significant strides in the pharmaceutical industry. For more information, please visit forgebiologics.com.